Form 8-K - Current report:
SEC Accession No. 0000950170-24-125357
Filing Date
2024-11-12
Accepted
2024-11-12 16:07:51
Documents
12
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K tsbx-20241112.htm   iXBRL 8-K 44104
2 EX-99.1 tsbx-ex99_1.htm EX-99.1 120145
  Complete submission text file 0000950170-24-125357.txt   292930

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT tsbx-20241112.xsd EX-101.SCH 26014
14 EXTRACTED XBRL INSTANCE DOCUMENT tsbx-20241112_htm.xml XML 4923
Mailing Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037
Business Address 9310 ATHENA CIRCLE, SUITE 300 LA JOLLA CA 92037 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41747 | Film No.: 241448074
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)